Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05563766
Title A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Palo Alto Health Care System, Palo Alto, CA Palo Alto California 94304-1290 United States Details
VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor Michigan 48105-2303 United States Details
Durham VA Medical Center, Durham, NC Durham North Carolina 27705 United States Details
VA Portland Health Care System, Portland, OR Portland Oregon 97239 United States Details
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX Dallas Texas 75216-7167 United States Details
Michael E. DeBakey VA Medical Center, Houston, TX Houston Texas 77030 United States Details
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field